Health Care & Life Sciences » Pharmaceuticals | Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$98.08 M
Shares Outstanding
13.51 M
Public Float
12.42 M


400 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Updated 07/08/2019
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing proprietary therapeutics primarily for the treatment of medical disorders. Its products include Probuphine, provides non fluctuating blood levels of buprenorphine; Ropinirole implant, which provides dopaminergic stimulation; and T3 implant, which is used in hypothyroidism treatment. Its products are subdermal implants, which utilizes ProNeura drug delivery platform.


View All

Marc Rubin
Executive Chairman
Sunil Bhonsle
President, Chief Executive Officer, CFO & Director